Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome

Autor: Hendricks, Linda A J, Hoogerbrugge, Nicoline, Mensenkamp, Arjen R, Brunet, Joan, Lleuger-Pujol, Roser, Høberg-Vetti, Hildegunn, Haavind, Marianne Tveit, Innella, Giovanni, Turchetti, Daniela, Aretz, Stefan, Spier, Isabel, Tischkowitz, Marc, Jahn, Arne, Links, Thera P, Olderode-Berends, Maran J W, Blatnik, Ana, Leter, Edward M, Evans, D Gareth, Woodward, Emma R, Steinke-Lange, Verena, Anastasiadou, Violetta C, Colas, Chrystelle, Villy, Marie-Charlotte, Benusiglio, Patrick R, Gerasimenko, Anna, Barili, Valeria, Branchaud, Maud, Houdayer, Claude, Tesi, Bianca, Yazicioglu, M Omer, van der Post, Rachel S, Schuurs-Hoeijmakers, Janneke H M, Vos, Janet R

Publikováno v: Journal of the National Cancer Institute. Oxford University Press
Journal of the National Cancer Institute, 115(1), 93-103. Oxford University Press
Journal of the National Cancer Institute, 115, 93-103
Journal of the National Cancer Institute, 115, 1, pp. 93-103
PTEN Study Group 2023, ' Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome ', Journal of the National Cancer Institute, vol. 115, no. 1, pp. 93-103 . https://doi.org/10.1093/jnci/djac188

Background PTEN Hamartoma Tumor Syndrome (PHTS) is a rare syndrome with a broad phenotypic spectrum, including increased risks of breast (BC, 67%-78% at age 60 years), endometrial (EC, 19%-28%), and thyroid cancer (TC, 6%-38%). Current risks are like

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15488006c0a9820b2ccee609e3f8a26c
https://cris.maastrichtuniversity.nl/en/publications/f3630f3a-f3af-4c92-9bd4-b59efd9de145